Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$3.67B |
| 2 |
Apple
AAPL
|
+$1.5B |
| 3 |
Tesla
TSLA
|
+$1.38B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.27B |
| 5 |
Mastercard
MA
|
+$1.1B |
Top Sells
| 1 |
Honeywell
HON
|
+$1.28B |
| 2 |
Phillips 66
PSX
|
+$651M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$503M |
| 4 |
Materials Select Sector SPDR Fund
XLB
|
+$425M |
| 5 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$377M |
Sector Composition
| 1 | Technology | 28.23% |
| 2 | Financials | 14.76% |
| 3 | Consumer Discretionary | 11.75% |
| 4 | Healthcare | 8.95% |
| 5 | Communication Services | 8.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Aclaris Therapeutics
ACRS
$211M
| $182K | ﹤0.01% |
119,001
+103,800
| +683% | +$159K |
|
3277
Blue Foundry Bancorp
BLFY
$198M
| $182K | ﹤0.01% |
19,767
-10,464
| -35% | -$96.3K |
|
3278
Provident Bancorp
PVBC
$226M
| $182K | ﹤0.01% |
15,819
-7,756
| -33% | -$89.2K |
|
3279
Stereotaxis
STXS
$260M
| $182K | ﹤0.01% |
103,974
-9,065
| -8% | -$15.9K |
|
3280
Symbotic
SYM
$5.32B
| $182K | ﹤0.01% |
9,014
+252
| +3% | +$5.09K |
|
3281
Ternium
TX
$6.8B
| $182K | ﹤0.01% |
5,850
+5,774
| +7,597% | +$180K |
|
3282
FT Vest US Equity Enhance & Moderate Buffer ETF October
XOCT
$117M
| $182K | ﹤0.01% |
5,379
-457
| -8% | -$15.5K |
|
|
XAPR
3283
FT Vest U.S. Equity Enhance & Moderate Buffer ETF - April
XAPR
$51.8M
| $182K | ﹤0.01% |
5,554
+606
| +12% | +$19.9K |
|
3284
Brookfield Renewable
BEP
$7.19B
| $181K | ﹤0.01% |
8,123
+125
| +2% | +$2.79K |
|
|
CRGX
3285
DELISTED
CARGO Therapeutics
CRGX
| $181K | ﹤0.01% |
44,193
-20,243
| -31% | -$82.9K |
|
3286
Innovator US Equity Buffer ETF June
BJUN
$180M
| $180K | ﹤0.01% |
4,453
+667
| +18% | +$27K |
|
3287
Definitive Healthcare
DH
$432M
| $180K | ﹤0.01% |
62,178
-29,134
| -32% | -$84.3K |
|
3288
Eos Energy Enterprises
EOSE
$2.29B
| $180K | ﹤0.01% |
47,425
-10,953
| -19% | -$41.6K |
|
3289
Zeekr
ZK
$7.45B
| $180K | ﹤0.01% |
7,492
+386
| +5% | +$9.27K |
|
3290
Luminar Technologies
LAZR
$129M
| $179K | ﹤0.01% |
33,181
-31,887
| -49% | -$172K |
|
3291
Lifecore Biomedical
LFCR
$281M
| $179K | ﹤0.01% |
25,454
-8,518
| -25% | -$59.9K |
|
3292
Tilray
TLRY
$1.25B
| $179K | ﹤0.01% |
271,367
+64,030
| +31% | +$42.2K |
|
3293
Innovator US Equity Ultra Buffer ETF July
UJUL
$217M
| $179K | ﹤0.01% |
+5,335
| New | +$179K |
|
3294
Innovator US Equity Accelerated ETF October
XDOC
$3.38M
| $179K | ﹤0.01% |
6,108
+6,019
| +6,763% | +$176K |
|
3295
Innovator Uncapped Accelerated US Equity ETF
XUSP
$50M
| $179K | ﹤0.01% |
+4,795
| New | +$179K |
|
3296
Quad
QUAD
$333M
| $178K | ﹤0.01% |
32,607
-15,457
| -32% | -$84.4K |
|
3297
Candel Therapeutics
CADL
$263M
| $177K | ﹤0.01% |
31,322
-2,995
| -9% | -$16.9K |
|
3298
Evolution Petroleum
EPM
$179M
| $177K | ﹤0.01% |
34,255
-15,054
| -31% | -$77.8K |
|
3299
FVCBankcorp
FVCB
$240M
| $177K | ﹤0.01% |
16,784
-8,287
| -33% | -$87.4K |
|
3300
Itaú Unibanco
ITUB
$75B
| $177K | ﹤0.01% |
32,232
-320,887
| -91% | -$1.76M |
|